New Study Reveals Alarming Levels of PFAS Chemicals in Fetal Blood

Emily Watson, Health Editor
5 Min Read
⏱️ 3 min read

Recent research has unveiled that fetuses may be exposed to significantly higher levels of per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” than previously understood. A comprehensive study conducted by Mount Sinai has tested 120 samples of umbilical cord blood, revealing the presence of 42 distinct PFAS compounds. This finding raises urgent concerns about the potential health risks associated with chemical exposure during a critical developmental phase.

Expanded Research Methodology

Traditionally, testing of umbilical cord blood has focused on a limited number of PFAS compounds, primarily perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, the Mount Sinai study employed an innovative “non-targeted analysis,” which allowed researchers to detect a much broader range of these chemicals. This approach identified an extensive array of PFAS that had previously gone unnoticed in the samples.

Co-author Shelley Liu, an associate professor at the Icahn School of Medicine, emphasised the significance of these findings, stating, “Babies are exposed to many more PFAS than we previously thought. It is particularly important to understand because it is a very vulnerable period when fetuses are exposed.”

PFAS, a group of around 15,000 synthetic compounds, are used widely in various consumer products due to their water, stain, and grease resistance. Unfortunately, they have also been linked to a plethora of health issues, including cancer, birth defects, and immune system dysfunction. Their persistence in the environment and the human body has earned them the moniker “forever chemicals.”

Health Implications for Infants

The study’s results suggest that elevated levels of PFAS in umbilical cord blood could have dire implications for infant health. Previous reviews of 40 studies have shown that PFAS have been detected in approximately 30,000 umbilical cord blood samples, highlighting the ubiquity of these chemicals. Increased maternal exposure to PFAS correlates with numerous adverse outcomes, including higher rates of infant mortality, low birth weight, and obesity in later life.

Health Implications for Infants

Moreover, fetal exposure to these substances has been associated with long-term health complications, such as cancer and cardiovascular disease. However, the Mount Sinai study did not directly investigate the health effects of the detected PFAS levels. Liu acknowledged that while the precise impacts remain uncertain, there is a general correlation between heightened PFAS levels and an increased risk of health problems.

Regulatory Challenges

The research underscores the inadequacies of current regulatory frameworks in monitoring and managing PFAS exposure. For instance, the US Environmental Protection Agency (EPA) typically tests for only 30 to 40 PFAS compounds in water samples, despite independent studies revealing thousands present. This discrepancy highlights the urgent need for improved detection methods and regulatory oversight to protect public health.

While the EPA has recently certified a blood test that identifies 53 PFAS compounds, the Mount Sinai study found 31 additional compounds that are not included in the EPA’s testing parameters. This suggests that the potential health risks associated with PFAS exposure may be grossly underestimated.

David Andrews, acting chief science officer at the Environmental Working Group, remarked, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”

Why it Matters

The findings of this study are a wake-up call regarding the pervasive nature of PFAS in our environment and their alarming presence in fetal blood. As we continue to uncover the extent of chemical exposure during pregnancy, it becomes increasingly clear that proactive measures are essential to safeguard the health of future generations. The implications of these findings stress the need for more rigorous regulations and comprehensive testing, ensuring that our most vulnerable populations are protected from potential harm.

Why it Matters
Share This Article
Emily Watson is an experienced health editor who has spent over a decade reporting on the NHS, public health policy, and medical breakthroughs. She led coverage of the COVID-19 pandemic and has developed deep expertise in healthcare systems and pharmaceutical regulation. Before joining The Update Desk, she was health correspondent for BBC News Online.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy